New drug IMP761 put to the test in healthy volunteers – no cure expected
Knowledge-focused
Recruiting now
This early-stage study tests whether a new drug called IMP761 is safe in healthy adults aged 18 to 55. Participants receive either the drug or a placebo and are closely monitored for side effects and changes in vital signs. The study does not aim to treat any disease, but to gath…
Phase: PHASE1 • Sponsor: Immutep S.A.S. • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC